REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES

Bibliografiska uppgifter
Huvudupphovsmän: Alton, E, Boyd, A, Cheng, S, Davies, J, Davies, L, Dayan, A, Gill, DR, Griesenbach, U, Higgins, T, Hyde, S, Innes, A, McLachlan, G, Porteous, D, Pringle, I, Scheule, R, Sumner-Jones, S
Materialtyp: Conference item
Publicerad: 2012

Liknande verk